JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
Author: OrthoBuzz for Surgeons
This commentary comes from guest contributor Matthew Deren, MD, in response to a recent study in The New England Journal of Medicine. To cement or
Improving Our Ability to Predict Discharge Disposition After Primary Total Hip and Knee Arthroplasty
The majority of patients who undergo primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) are discharged to home postoperatively, but for some patients,
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
When patients present with identified bone metastases, a known primary diagnosis, and pain, the orthopaedic surgeon is nearly always contacted. The treatment plan is guided
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
February 17, 2022 – For patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic drugs (bDMARDs) prior to orthopaedic surgery does
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
JBJS recently welcomed Antonia F. Chen, MD, MBA as Deputy Editor for Adult Reconstruction. Dr. Chen is an orthopaedic surgeon in Boston, Massachusetts. She also